Vatalanib
Showing 1 - 25 of 40
Solid Tumor Trial in Los Angeles (warfarin)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Aug 3, 2020
Solid Tumor Trial in Rochester (drug, other, procedure)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- vatalanib
- +3 more
-
Rochester, MinnesotaMayo Clinic
Apr 4, 2019
Brain and CNS Tumors, Sarcoma Trial in Chicago, Seattle (vatalanib)
Completed
- Brain and Central Nervous System Tumors
- Sarcoma
- vatalanib
-
Chicago, Illinois
- +2 more
Oct 24, 2018
Colorectal Tumors, Colonic Tumors, Rectal Tumors Trial in Worldwide (Vatalanib)
Completed
- Colorectal Neoplasms
- +2 more
- Vatalanib
-
Birmingham, Alabama
- +222 more
Feb 6, 2020
Angiogenesis and Disease in Unresectable Malignant Mesothelioma
Terminated
- Malignant Mesothelioma
- immunoenzyme technique
- laboratory biomarker analysis
- (no location specified)
Jan 22, 2019
Osteosarcoma, Metastasis Trial in Beijing (apatinib)
Completed
- Osteosarcoma
- Metastasis
-
Beijing, Beijing, ChinaPeking University People's Hospital
Apr 19, 2018
Kidney Cancer, Solid Tumor Trial in Durham (RAD001 (everolimus), PTK787 (vatalanib))
Completed
- Kidney Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- RAD001 (everolimus)
- PTK787 (vatalanib)
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Mar 1, 2016
Colorectal Tumors, Colonic Tumors, Rectal Tumors Trial in Worldwide (Vatalanib)
Completed
- Colorectal Neoplasms
- +2 more
- Vatalanib
-
Huntsville, Alabama
- +250 more
Mar 2, 2017
Gastrointestinal Carcinoid Tumor, Islet Cell Carcinoma Trial (octreotide acetate, vatalanib, anti-cytokine therapy)
Withdrawn
- Gastrointestinal Carcinoid Tumor
- Islet Cell Carcinoma
- octreotide acetate
- +10 more
- (no location specified)
Oct 6, 2015
Brain and CNS Tumors Trial in Durham (hydroxyurea, imatinib mesylate, vatalanib)
Completed
- Brain and Central Nervous System Tumors
- hydroxyurea
- +2 more
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Oct 11, 2015
Von Hippel-Lindau Disease, CNS Hemangioblastoma, Retinal Hemangioblastoma Trial in Boston, Durham (PTK787/ZK 222584)
Completed
- Von Hippel-Lindau Disease
- +2 more
- PTK787/ZK 222584
-
Boston, Massachusetts
- +1 more
Mar 2, 2017
Malignant Mesothelioma Trial in United States (PTK787/ZK 222584)
Completed
- Malignant Mesothelioma
- PTK787/ZK 222584
-
Anniston, Alabama
- +79 more
Jun 30, 2016
Esophageal Cancer, Metastatic Esophageal Cancer, Apatinib Trial in Hangzhou (Apatinib)
Unknown status
- Esophageal Cancer
- +2 more
-
Hangzhou, Zhejiang, ChinaHangzhou Cancer Hospital
Aug 25, 2016
Pancreatic Cancer Trial in Stanford (Vatalanib, Gemcitabine)
Completed
- Pancreatic Cancer
- Vatalanib
- Gemcitabine
-
Stanford, CaliforniaStanford University School of Medicine
Sep 10, 2014
Non Small Cell Lung Cancer Trial in France, Germany (SH T00268C, PTK787/ ZK 222584)
Completed
- Non Small Cell Lung Cancer
- SH T00268C
- PTK787/ ZK 222584
-
Paris, France
- +5 more
Dec 14, 2014
Tumor Metastasis, Carcinoma Trial in Indianapolis (Paclitaxel plus PTK787)
Completed
- Neoplasm Metastasis
- Carcinoma
- Paclitaxel plus PTK787
-
Indianapolis, IndianaIndiana University Simon Cancer Center
Sep 10, 2014
Melanoma (Skin) Trial in Cambridge, Leicester (vatalanib)
Completed
- Melanoma (Skin)
- vatalanib
-
Cambridge, England, United Kingdom
- +1 more
Aug 1, 2013
Multiple Myeloma Trial in St. Louis (PTK787/ZK 222584)
Terminated
- Multiple Myeloma
- PTK787/ZK 222584
-
St. Louis, MissouriWashington University School of Medicine
Sep 5, 2014